At this time, there is no known cure for Pleuropulmonary blastoma type 1. Treatment typically involves a combination of chemotherapy, radiation therapy, and surgery. Medications used to treat this condition may include chemotherapy drugs, such as vincristine, doxorubicin, and cyclophosphamide, as well as targeted therapies, such as imatinib and sunitinib.

1. Genetic predisposition: Pleuropulmonary blastoma type 1 is associated with a genetic predisposition, with mutations in the DICER1 gene being the most common.

2. Family history: A family history of pleuropulmonary blastoma type 1 or other DICER1-related tumors increases the risk of developing the condition.

3. Age: Pleuropulmonary blastoma type 1 is most commonly diagnosed in children under the age of 10.

4. Gender: Pleuropulmonary blastoma type 1 is more common in males than females.

5. Race: Pleuropulmonary blastoma type 1 is more common in Caucasians than other racial groups.

The treatment for Pleuropulmonary blastoma type 1 typically involves a combination of surgery, chemotherapy, and radiation therapy. Surgery is usually the first step in treatment and may involve removing the tumor and any affected lymph nodes. Chemotherapy is then used to kill any remaining cancer cells. Radiation therapy may also be used to reduce the risk of the cancer returning. In some cases, a stem cell transplant may be recommended.

Pleuropulmonary blastoma type 1 (PPB1) is a rare type of cancer that affects the lungs and chest wall. It is caused by a mutation in the gene called TP63. This gene is responsible for controlling the growth and development of cells in the lungs and chest wall. The exact cause of this mutation is unknown, but it is believed to be related to environmental factors, such as exposure to certain chemicals or radiation.

The symptoms of Pleuropulmonary blastoma type 1 vary depending on the size and location of the tumor. Common symptoms include chest pain, shortness of breath, coughing, wheezing, and recurrent respiratory infections. Other symptoms may include fever, weight loss, fatigue, and difficulty swallowing.

Pleuropulmonary blastoma type 1 (PPB1) is a rare type of cancer that affects the lungs and chest wall. It is a type of malignant mesenchymal tumor that usually affects children under the age of 10. It is characterized by the presence of a tumor in the pleura (the lining of the lungs) and/or the pulmonary parenchyma (the tissue of the lungs). Symptoms of PPB1 include chest pain, difficulty breathing, and coughing up blood. Treatment typically involves surgery, chemotherapy, and/or radiation therapy.